Rakuten Medical

Rakuten Medical, Inc. is a global biotechnology company headquartered in San Diego, California, developing precision, cell-targeting investigational cancer therapies on its proprietary Alluminox platform — a drug-device combination pairing an IRDye 700DX light-activated dye conjugated to a cell-targeting antibody with local illumination by 690nm red light. Founded in 2010 as Aspyrian Therapeutics and renamed following investment from Rakuten Group, the company operates in the United States, Japan, Taiwan, Switzerland and India. Its lead asset ASP-1929, an EGFR-targeting antibody-dye conjugate, received marketing approval in Japan in 2021 as Akalux for unresectable locally advanced or recurrent head and neck cancer and is in global Phase 3 development alone and in combination with anti-PD-1 therapy; RM-1995 and RM-0256 follow in earlier-stage programs. As a clinical-stage therapeutics and drug-device company, Rakuten Medical publishes no public developer API, SDK, webhook, or machine-readable specification; this profile captures its corporate identity and public web properties in the API Evangelist network.

Rakuten Medical is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Healthcare.

Rakuten Medical’s developer surface includes engineering blog, product news, support, and 9 more developer resources.

9.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyPharmaceuticalsOncologyHealthcareLife SciencesPhotoimmunotherapyMedical DevicesClinical TrialsCancer

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 9.6/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 1.1 / 17
Commercial Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/rakuten-medical: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Rakuten Medical Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 7

The organization behind the API

Scroll for all 7

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: rakuten-medical
name: Rakuten Medical
image: https://rakuten-med.com/us/wp-content/uploads/sites/6/2021/02/RakutenMedical_KV.png
description: Rakuten Medical, Inc. is a global biotechnology company headquartered in San Diego, California, developing precision,
  cell-targeting investigational cancer therapies on its proprietary Alluminox platform — a drug-device combination pairing
  an IRDye 700DX light-activated dye conjugated to a cell-targeting antibody with local illumination by 690nm red light. Founded
  in 2010 as Aspyrian Therapeutics and renamed following investment from Rakuten Group, the company operates in the United
  States, Japan, Taiwan, Switzerland and India. Its lead asset ASP-1929, an EGFR-targeting antibody-dye conjugate, received
  marketing approval in Japan in 2021 as Akalux for unresectable locally advanced or recurrent head and neck cancer and is
  in global Phase 3 development alone and in combination with anti-PD-1 therapy; RM-1995 and RM-0256 follow in earlier-stage
  programs. As a clinical-stage therapeutics and drug-device company, Rakuten Medical publishes no public developer API, SDK,
  webhook, or machine-readable specification; this profile captures its corporate identity and public web properties in the
  API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/rakuten-medical/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Healthcare
- Life Sciences
- Photoimmunotherapy
- Medical Devices
- Clinical Trials
- Cancer
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/rakuten-medical-domain-security.yml
- type: LLMsTxt
  url: llms/rakuten-medical-llms.txt
- type: Website
  url: https://rakuten-med.com/us/
- type: About
  url: https://rakuten-med.com/us/about/
- type: Blog
  url: https://rakuten-med.com/us/news/
- type: BlogRSS
  url: https://rakuten-med.com/us/feed/
- type: News
  url: https://rakuten-med.com/us/news/press-releases/
- type: Support
  url: https://rakuten-med.com/us/contact/
- type: Careers
  url: https://rakuten-med.com/us/recruitment/
- type: PrivacyPolicy
  url: https://rakuten-med.com/us/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/rakuten-medical/
- type: Profile
  url: https://forgeglobal.com/rakuten-medical_stock/
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Rakuten Medical is a clinical-stage biotechnology company whose product is a drug-device cancer therapy (an IRDye
    700DX antibody conjugate plus a 690nm laser), sold to hospitals and regulated by PMDA and FDA rather than integrated by
    developers; its only web property is a WordPress corporate site, and the sole non-www host that resolves, portal.rakuten-med.com,
    is an F5 BIG-IP employee VPN that answers 200 with the same HTML logout page for every path.
  evidence:
  - url: https://rakuten-med.com/us/openapi.json
    status: 404
  - url: https://rakuten-med.com/us/.well-known/api-catalog
    status: 404
  - url: https://rakuten-med.com/us/.well-known/agent-card.json
    status: 404
  - url: https://rakuten-med.com/us/llms.txt
    status: 404
  - url: https://rakuten-med.com/us/developers
    status: 404
  - url: https://portal.rakuten-med.com/.well-known/agent-card.json
    status: 200
  - url: https://rakuten-med.com/us/pipeline/
    status: 200
  checked: '2026-08-05'